Feeds

Steve Jobs had liver transplant

Apple return may be part-time

3 Big data security analytics techniques

Sometime in April, roughly three months after taking a medical leave of absence from the Apple CEO post, Steve Jobs received a liver transplant.

News of the two-month-old transplant broke late Friday evening, at the end of a day when Apple released the latest incarnation of its worldwide status symbol, the iPhone 3G S.

As reported by The Wall Street Journal, Jobs is recovering well and will return to work by the end of the month. His participation in Apple's affairs, however, could be only on a part-time basis.

In August 2004, Jobs announced he had undergone surgery to remove a cancerous tumor from his pancreas. Since then, the health of the Apple co-founder has been an endless source of speculation.

In mid-2008, when he turned up at Apple's Worldwide Developer Conference in July to unveil the first 3G iPhone, he was noticeably thinner than usual, and after days of questions from the press and blogosphere, The New York Times reported Jobs had "assured several people" he was cancer free.

Then, on January 5, Jobs assured the world he had a "hormonal imbalance" that was "relatively simple and straightforward" to treat. But just nine days later, he announced a six-month leave of absence, saying he needed to focus on health issues that were "more complex" than he first thought.

Along the way, Jobs was widely criticized for not revealing the full extent of his health problems to Apple shareholders. Unlike the average CEO, Jobs is viewed as an essential driving force behind the company's cult-like success, and Apple's share price tends to rise and fall according to the latest speculation on his health. One Friday morning in October, Apple shares fell as much as 5.4 per cent after a so-called citizen journalist erroneously reported that the Apple CEO has suffered a major heart attack.

Apple is famously tight-lipped about, well, just about everything, and chances are, it's no accident that news of Jobs' liver transplant arrived after the market had closed for the weekend, at the sleepiest point in the weekly news cycle, on a day when Apple had re-exerted its hold on the smartphone market.

Quoting a doctor who has not treated Jobs, The Wall Street Journal said that the type of pancreatic tumor Jobs had - known as an islet cell neuroendocrine tumor - will often metastasize in another organ, usually the liver. "All total, 75% of patients are going to have the disease spread over the course of their life," the doctor said.

Livers are hard to come by, and according to The Journal, Jobs had his transplant in Tennessee, where the waiting list is shorter than in most US states. The United Network for Organ Sharing says that the average wait time is 306 days, as opposed to only 48 days in Tennessee.

An unnamed source speaking with The Journal said that Jobs may be encouraged by his doctors to "work part-time for a month or two." This may mean Apple COO Tim Cook taking on "a more encompassing role." The source also said that Cook may soon be appointed to the Apple board. ®

Combat fraud and increase customer satisfaction

More from The Register

next story
Dropbox defends fantastically badly timed Condoleezza Rice appointment
'Nothing is going to change with Dr. Rice's appointment,' file sharer promises
Audio fans, prepare yourself for the Second Coming ... of Blu-ray
High Fidelity Pure Audio – is this what your ears have been waiting for?
Record labels sue Pandora over vintage song royalties
Companies want payout on recordings made before 1972
MtGox chief Karpelès refuses to come to US for g-men's grilling
Bitcoin baron says he needs another lawyer for FinCEN chat
Ex–Apple CEO John Sculley: Ousting Steve Jobs 'was a mistake'
Twenty-nine years later, post-Pepsi exec has flat-forehead moment
Number crunching suggests Yahoo! US is worth less than nothing
China and Japan holdings worth more than entire company
Zucker punched: Google gobbles Facebook-wooed Titan Aerospace
Up, up and away in my beautiful balloon flying broadband-bot
prev story

Whitepapers

Securing web applications made simple and scalable
In this whitepaper learn how automated security testing can provide a simple and scalable way to protect your web applications.
3 Big data security analytics techniques
Applying these Big Data security analytics techniques can help you make your business safer by detecting attacks early, before significant damage is done.
The benefits of software based PBX
Why you should break free from your proprietary PBX and how to leverage your existing server hardware.
Top three mobile application threats
Learn about three of the top mobile application security threats facing businesses today and recommendations on how to mitigate the risk.
Combat fraud and increase customer satisfaction
Based on their experience using HP ArcSight Enterprise Security Manager for IT security operations, Finansbank moved to HP ArcSight ESM for fraud management.